Global Stem Cells Group Subsidiary Adimarket Named Latin American Distributor for Ranfac Bone Marrow Technology

Share Article

Global Stem Cells Group has been named distributor in Latin America for medical device manufacturer Ranfac Corporation’s bone marrow technology.

stemlab,stem cells, stem cell therapies,liposculpture,plastic surgery

Global Stem Cells Group

Ranfac's ground-breaking hematology and orthopedic products for bone marrow access, aspiration, stem cell harvesting and biopsy procedures are designed to provide a more efficient result during critical procedures.

Global Stem Cells Group subsidiary Adimarket has been named the Latin America distributor for bone marrow technology leader Ranfac Corporation. The announcement coincides with Global Stem Cells Group’s most recent expansion plans in Latin America, an ongoing effort to meet the region’s growing demands for access to regenerative medicine and stem cell therapies.

Ranfac manufactures state-of-the-art surgical, radiology, hematology and orthopedic products including a range of bone marrow aspiration needles, each designed to provide a simple means of harvesting marrow from the patient’s sternum (breastbone) or the iliac crest (part of the pelvic bone) for a variety of medical procedures. Ranfac’s newest technology is designed to harvest high quality bone marrow derived cells without the need for centrifugation.

Ranfac bone marrow technology is used by physicians and medical specialists worldwide. Global Stem Cells Group Advisory Board member Joseph Purita, M.D., a pioneer in the use of laser and stem cell therapies in orthopedic medicine, endorses Ranfac’s bone marrow aspiration technology. Purita recently joined other specialists including fellow GSCG Advisory Board member David B Harrell, PhD, Brt, OF, FAARM, FRIPH, DABRM, in a trial study and white paper collaboration on Ranfac’s new, non-centrifugal bone marrow technology.

Both Purita and Harrell endorse the Ranfac system’s enhanced safety and ability to increase the concentrations of stem and progenitor cells during the bone marrow aspiration process.

“Our ground-breaking hematology and orthopedic products for bone marrow access, aspiration, stem cell harvesting and biopsy procedures are designed to provide a more efficient result during critical procedures,” says Ranfac CEO Barry Zimble. “We believe that this is the perfect time to team with Global Stem Cells Group as our distribution partner in Latin America’s fast-growing medical community.”

The collaboration between Global Stem Cells Group and Ranfac is another step toward GSCG’s commitment to expanding its presence in communities that need and deserve access to cutting-edge regenerative medicine, not only in Latin America but also worldwide.

“The timing couldn’t be better to represent Ranfac’s cutting edge bone marrow technology in the emerging markets of Latin America. Global is always looking to provide patients and practitioners with the best resources that regenerative medicine has to offer” says Ricardo DeCubas, Global Stem Cells Group co-founder and Regenestem CEO.

For more information visit the Global Stem Cells Group website, email, or call 305-224-1858.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Adimarket:

Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.

Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor's office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.

About Ranfac Corporation:

America’s premier single-source medical device manufacturing facility, Ranfac Corporation’s experience, passion and dedication to excellence in medical device manufacturing is the secret to the company’s success. Founded in 1888, Ranfac has survived multiple depressions and recessions, all along building its reputation as an industry leader in developing and manufacturing precision medical instruments.

Ranfac’s single-source medical device manufacturing process, from concept and design to packaging and distribution, is unmatched. To learn more, visit the Ranfac website at


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Benito Novas

Liz Ernst
Email >
since: 06/2014
Follow >
Global Stem Cells Group
since: 08/2012
Like >

Follow us on